New York, NY (May 20, 2020) – Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced that Brian Stevens, executive chairman of Neural Magic, has joined its board of directors. The appointment is effective immediately.
37% of SMBs Have Lost Customers and 17% Have Lost Revenue Due to Downtime
Experienced Product Leader Joins Leadership Team Committed to Delivering Powerful, Differentiated Value to Customers
Saama and iNDX.Ai Launch New COVID-19 Command Center Analytics Platform To Expedite Clinical Research Efforts by Individual Sponsors
Campbell, CA (May 5, 2020) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, and iNDX.Ai, a leading Multi-omics Data Analytics and translational research platform company, today announced the launch of the new COVID-19 Command Center. The COVID-19 Command Center, based on a combination of Saama’s Life Science Analytics Cloud (LSAC) and iNDX.Ai’s iCore Platform, is a purpose-built, therapeutic area-specific data analytics platform that will accelerate the ability of life sciences companies to expedite internal research and development programs for therapies to prevent and treat COVID-19.
Mavenlink Future of Work Survey Shows a Majority of Employees Feel Trust Is Important for Workplace Culture
Data Suggests Building Trust Across Generations Requires Multifaceted Approach
Elissa Fink and Bobby Morrison join Saviynt's Board of Advisors
And Nearly Three Out of Four of Those SMBs Have Paid the Ransom
Interactive virtual training courses make it easy for individuals and organizations to step up their cyber skills from home
C-Level Executives’ Primary Data Protection Concerns Diverge By Sector – Data Security and Encryption Are Most Important in Legal, Data Backup and Recovery Are Top Priority in Education
Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data from all Organizations Investigating COVID-19 Treatments
Open Invitation Issued to Corporate and Government Organizations to Mitigate Pandemic
Complia Health Secures Five-Year ContinuLink Contract Extension with Interim HealthCare Franchise Network
Complia Health and the Interim HealthCare franchise network continue a close, longstanding partnership and have extended a many-year agreement following a decade of proven success.
Seattle, WA (February 28, 2020) – Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Accolade intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol ACCD.
Saama’s Growth Strategy Continues with Addition of Jonathan Burr and Gregory Simpson to Leadership Team
Campbell, CA (February 18, 2020) - Saama Technologies, Inc. (“Saama”), the number one AI clinical analytics platform company, announced today that it recently expanded its leadership team to include life science technology expert Jonathan Burr as Senior Vice President of Clinical Platform Strategy, and technology marketing leader Gregory T. Simpson as Vice President, Head of Marketing. Jonathan is responsible for growing client adoption of Saama’s existing products, and Greg is charged with building and strengthening the Saama brand. The announcement came at the start of the 11th Annual Summit for Clinical Ops Executives (SCOPE) meeting in Orlando.
Campbell, CA (February 18, 2020) - Saama Technologies, Inc., the number one AI clinical analytics platform company, announced today that it signed an agreement with Pfizer Inc. to develop and deploy an AI-powered analytics solution to reduce the challenges commonly experienced by clinical study data managers and monitors. Under this agreement, Saama’s award-winning Life Science Analytics Cloud (LSAC) platform will aggregate, transform, analyze, model and predict clinical data queries using deep learning techniques. Pfizer will provide the required ground truth clinical data and domain expertise to train Saama models to achieve the required accuracy.
Saviynt Announces the Return of Converge EMEA Conference on March 11th, 2020, Featuring Keynote Speaker Dex Torricke-Barton
Mavenlink Announces Executive Advisory Board to Provide Guidance on Strategy and Go-to-market Priorities
Founding Members Keith Carlson, Ed Marshall, and Walt Weisner Bring Deep Services Industry, Consulting, and Product Expertise
Infrascale appoints high-growth, tech industry veteran Russell P. Reeder as CEO, makes several new additions to its leadership team, and secures new funding led by existing investors
Pet Peeves and Other People-Related Productivity Killers Highlight Importance of Team Building
Saviynt and STEALTHbits Technical Alliance & OEM Agreement Combines DAG with IGA to Bring Governance to Unstructured Data
El Segundo, CA (January 22, 2020) - Saviynt (www.saviynt.com), an industry leader pioneering Identity 3.0 - a disruptive, converged Identity Governance, Application GRC, and Cloud Privileged Access Management solution, is announcing an Original Equipment Manufacturer (OEM) agreement with STEALTHbits and the launch of a joint Go to Market in 2020.
New York, NY (January 21, 2020) - Factor, formerly Axiom Managed Solutions (AMS), the leader in next-generation solutions for complex legal work at scale, today announced it has named Varun Mehta CEO. Mehta's appointment comes as the newly rebranded company embarks on an ambitious growth agenda with plans to expand its market leadership and a recommitment from Axiom's original investors including Carrick Capital and Benchmark Capital.